Abstract
ST-segment elevation myocardial infarction (STEMI) is considered a cardiology emergency requiring immediate recognition and treatment aimed at successful and early reperfusion to ensure optimal outcomes. The American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA) have issued guidelines for the diagnosis and management of patients with acute myocardial infarction since 1990. These guidelines are based on clinical research exploring reperfusion modalities and adjunctive therapies. They are further supported by expert opinion where randomized trial evidence is lacking. In January 2013, the ACCF/AHA released the most recent guidelines for the management of patients with STEMI. This review focuses on the newest and most important recommendations taken from the 2013 ACCF/AHA Guidelines for the Management of STEMI and highlight important new studies that have emerged over the past year.
| Original language | English |
|---|---|
| Pages (from-to) | 252-259 |
| Number of pages | 8 |
| Journal | Clinical Cardiology |
| Volume | 37 |
| Issue number | 4 |
| DOIs | |
| State | Published - Apr 2014 |
| Externally published | Yes |
Fingerprint
Dive into the research topics of 'Highlights from the 2013 ACCF/AHA guidelines for the management of ST-elevation myocardial infarction and beyond'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver